Lisa Takagi

1 week ago | insights.citeline.com | Lisa Takagi

Japan Price Cuts For Epkinly and Lunsumio Following CEAWegovy, Leqembi And Others In SpotlightJapan is cutting more drug reimbursement prices following cost effectiveness analysis and is applying the methodology to a new group of products including Wegovy and Leqembi. Japan cuts prices, looks at products under cost effectiveness scheme (Shutterstock/AI-generated)

1 week ago | insights.citeline.com | Lisa Takagi

Japan Reimburses 11 New Drugs But Slashes Price Of Others By Up To 20%Give And Take Under NHI Scheme Japan's NHI program continues to give and take as 11 new drugs are granted reimbursement, while the prices of others - including three ophthalmic therapies - are cut by up to 20% under a Market Expansion Repricing scheme. Japan balances health costs as it reimburses a batch a new drugs while cutting prices of other fast-expanding therapies. (Shutterstock/AI-generated)

2 weeks ago | insights.citeline.com | Lisa Takagi

Japan Pharma Sees US Revenues Grow But Policy Impact Still Unclear Major Firms Report Fiscal Year Results Japanese majors put in generally solid performances in the fiscal year ended 31 March, but overseas revenues and forex effects, rather than the domestic market, provided most of the growth. US a key driver of major Japanese pharma companies' growth last fiscal year. (Shutterstock/AI-generated)

2 weeks ago | insights.citeline.com | Joseph Haas |Xu Hu |Anju Ghangurde |Lisa Takagi

Asia Deal Watch: Lilly Partners With Rznomics On Hearing LossPlus deals involving Minghui/Qilu, LENZ/Lotus, Amicus/Dimerix, Sanofi/Dr. Reddy’s, Henlius/Lotus, Apnimed/Desitin, Formosa/Saval, DAAN/GC Cell, VelaVigo/Ollin and Sol-Gel/Mayne.

1 month ago | insights.citeline.com | Lisa Takagi

Japan Market Entry: Consortium’s One-Stop Shop To Support Foreign Entrants JEC Aims To Help Ventures Without Presence Japanese CDMO Bushu talks about a consortium designed to provide a broad range of development services to smaller foreign firms looking to bring high-need drugs to the Japanese market. JEC started by several firms in market expertise in Japan including Bushu Pharma. (Shutterstock)